Boston Scientific stock falls after a cyberattack and $46.71 quote
Published on 08/28/2026 at 20:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Boston Scientific stock (ISIN US10117L1017) trades at $46.71 as of August 28, 2026, while a cyberattack has disrupted parts of its global operations and the latest reported quarter delivered $5.44 billion in revenue and $0.86 in adjusted EPS.
Cyber disruption lands first
Boston Scientific said the incident is affecting systems used to process customer orders and ship products worldwide, and a report summarized the stock as down 3.2% with shares opening at $46.64 and a market value of $67.59 billion.
The same report put the 52-week range at $42.20 to $109.50, the 50-day moving average at $46.53, and the 200-day moving average at $56.72, leaving the stock close to the short-term trend line but well below the longer one.
Latest quarter still matters
The most recent reported quarter, on July 29, 2026, showed revenue of $5.44 billion, up 7.5% year over year, with adjusted EPS of $0.86 versus $0.75 a year earlier.
That quarter also carried a net margin of 17.50% and operating margin of 22.90%, while full-year 2026 guidance stood at $3.28 to $3.32 in EPS, a range that frames how much the cyber issue can matter if shipments stay under pressure.
Among peers, the setup looks mixed: Boston Scientific's consensus target in a market-data snapshot was $71.62, yet the shares were quoted at $46.69 intraday, a gap that leaves room for debate on valuation versus execution risk.
Product angle
Boston Scientific's portfolio spans devices for less-invasive procedures in cardiovascular, digestive, urologic, pulmonary and chronic-pain care, which means order delays can flow quickly into procedure timing and revenue recognition.
Stock level
Boston Scientific stock last changed hands at $46.71 as of August 28, 2026, with a market capitalization of $69.81 billion in the same data set. The quote sits just above the 50-day moving average of $46.54 and below the 200-day average of $68.42.
Fact box
Company: Boston Scientific Corporation
ISIN: US10117L1017
Ticker: BSX
Exchange: NYSE
Sector / Industry: Health Care / Medical Devices
Index membership: S&P 500
